Nephro Care India Past Earnings Performance
Past criteria checks 5/6
Nephro Care India has been growing earnings at an average annual rate of 80.8%, while the Healthcare industry saw earnings growing at 23.2% annually. Revenues have been growing at an average rate of 72.5% per year. Nephro Care India's return on equity is 29.4%, and it has net margins of 16.2%.
Key information
80.8%
Earnings growth rate
30.4%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | 72.5% |
| Return on equity | 29.4% |
| Net Margin | 16.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Nephro Care India makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 272 | 44 | 13 | 0 |
| 31 Mar 23 | 171 | 24 | 10 | 0 |
| 31 Mar 22 | 34 | 0 | 4 | 0 |
| 31 Mar 21 | 18 | 1 | 1 | 0 |
| 31 Mar 20 | 5 | 0 | 1 | 0 |
Quality Earnings: NEPHROCARE has a high level of non-cash earnings.
Growing Profit Margin: NEPHROCARE's current net profit margins (16.2%) are higher than last year (13.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NEPHROCARE's earnings have grown significantly by 80.8% per year over the past 5 years.
Accelerating Growth: NEPHROCARE's earnings growth over the past year (85.9%) exceeds its 5-year average (80.8% per year).
Earnings vs Industry: NEPHROCARE earnings growth over the past year (85.9%) exceeded the Healthcare industry 33.2%.
Return on Equity
High ROE: NEPHROCARE's Return on Equity (29.4%) is considered high.